Institute of Good Manufacturing Practices India
Global accredited training provider
Approved by Quality Council Of India (QCI), Government of India
An ISO 9001:2008 Certified Organisation
Registered under The Societies Registration Act,1860 Government of India
Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh
International Register of Certificated Auditors (IRCA) accredited Lead Auditor (FSMS) course
New Delhi | Noida | Hyderabad | Lucknow

Trusted by training participants in over 20 countries

Critical cGMP Global Operations Center for Genzyme Corporation, a Sanofi Company has been acquired by Capri EGM

Capri EGM is an investment company specializing in corporate sale leaseback and build-to-suit financing, and the acquisition of institutional quality single-tenant office, industrial, and retail net lease properties. Capri EGM has announced that it has acquired a critical cGMP global operations and distribution center for Genzyme, a Sanofi Company.

Genzyme is a global leader in rare disease pharmaceuticals, focusing on treatments for rare genetic, endocrine, and cardiovascular diseases in addition to multiple sclerosis. Genzyme operates 65 locations in 40 countries worldwide. The critical cGMP global operations and distribution center is used for the storage and distribution of Genzyme's pharmaceutical products, and was constructed to Current Good Manufacturing Practices (cGMP) standards which are set by the Food and Drug Administration to assure the identity, strength, quality and purity of drug products.

The acquisition will lead to durable cash flows, escalating annual rents, and attractive risk adjusted returns over time and across a variety of market conditions and economic cycles and will also lead to financial strength of Genzyme Corporation and its parent company Sanofi.



Contact Us